API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/04/12/2862133/0/en/Praxis-Precision-Medicines-to-Present-on-Ulixacaltamide-at-the-American-Academy-of-Neurology-2024-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/01/05/2804615/0/en/Praxis-Precision-Medicines-Announces-Licensing-and-Collaboration-Agreement-with-Tenacia-Biotechnology-for-Ulixacaltamide-in-Greater-China.html
https://www.globenewswire.com/news-release/2023/08/08/2720429/0/en/Praxis-Precision-Medicines-Announces-Positive-Data-from-Randomized-Withdrawal-Sub-Study-and-Long-Term-Extension-of-Essential1-Study-for-Ulixacaltamide.html
https://www.globenewswire.com/news-release/2023/06/09/2685440/0/en/Praxis-Precision-Medicines-Announces-Plans-to-Begin-Ulixacaltamide-Phase-3-in-Essential-Tremor-by-Year-End-After-Completing-End-of-Phase-2-Meeting-with-FDA.html
https://www.globenewswire.com/news-release/2023/04/17/2647849/0/en/Praxis-Precision-Medicines-Announces-Upcoming-Ulixacaltamide-Presentations-Events.html